Evolution in the ophthalmic space is rapidly changing in both diagnosis and treatment of common eye conditions. Clinical trials serve as a frame for physicians to learn about and practice evidence-based medicine. Specifically, in regard to anterior segment surgical care the innovation is blazing. The purpose of this lecture is to highlight the future of ophthalmic surgery and review a few of the technologies or treatments that are on the horizon by leveraging the speakers' experiences in clinical trials. The speakers will discuss some recently approved technologies as well as some that are in the final stages of clinical trials. Exciting technology discussions will revolve around intraocular lenses (IOLs), post-operative drug delivery, corneal surgeries, glaucoma drug delivery, and many more. The aim of the course will be to give a glimpse into the future for eyecare and what it means for our future.

Course Code:



Mitch Ibach, O.D.

Michael Greenwood, M.D.



AOA Expiration Date:


Related News

Doctors of optometry challenge reasoning behind proposed Eyeglass Rule changes at FTC workshop

The recent workshop heard testimony from various stakeholders on the potential impact that proposed changes to the Eyeglass Rule might have on consumer choice and the burden on the practices of doctors of optometry and ophthalmology, which are already understaffed and saddled with other federal regulation. The Federal Trade Commission will use the feedback to determine whether to go forward with its recommendations.

Common coding Qs answered

These are the coding questions your colleagues are asking—and the answers from the AOA’s experts could help you.

The heat is on: Ensure patients’ protective eyewear is, too

Some doctors of optometry may see an increase in patients seeking care during the summer months, whether they’re playing sports or battling dry air conditions. Be prepared to share your expertise.